NEW YORK (GenomeWeb) – IBM Watson Health announced today that it has signed an agreement making Baheal Pharmaceutical Group the primary channel partner for its Watson for Genomics platform in China.

Watson for Genomics is designed to analyze large sets of genomic, clinical, and pharmacological data to generate a report for physicians that identifies genetic alterations that are actionable based on literature, as well as drugs and clinical trials that target those alterations.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.